← All Sunshine Biopharma INC filings

Sunshine Biopharma INC S-1 registration statements

Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.

NASDAQ
SBFM
Sunshine Biopharma INC
S-1: Sunshine Biopharma Registers 15.5M Shares for Warrant Exercise
Sunshine Biopharma Inc. filed an S-1 registration statement to allow for the cash exercise of 15.5 million Series B Warrants, potentially raising $32 million, while navigating ongoing Nasdaq listing compliance challenges.
NASDAQ
SBFM
Sunshine Biopharma INC
S-1/A: Sunshine Biopharma Files Amended S-1 for Unit Offering
Sunshine Biopharma has amended its S-1 filing to update share information for a proposed unit offering.
NASDAQ
SBFM
Sunshine Biopharma INC
S-1: Sunshine Biopharma Eyes Public Offering to Fuel Oncology and Antiviral Drug Development
Sunshine Biopharma is launching a firm commitment, underwritten public offering of units to raise capital for general corporate purposes, including advancing its oncology and antiviral drug pipeline.